Surya P. Rednam, MD
- Cancer and Blood Disorders
Assistant Director, Clinical Division (Inpatient), Cancer and Hematology Center
Director, Childhood Cancer Prevention and Screening Clinic
Associate Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Office locations:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Surya P. Rednam, MD
Dr. Surya Rednam developed the Childhood Cancer Prevention and Screening Clinic for children who have a hereditary predisposition to cancer under the mentorship of Dr. Sharon Plon.
His clinical interests include childhood brain tumors and cancer screening for children with a hereditary predisposition to cancer.
Dr. Rednam is a member of the Brain Tumor Program, the Cancer Genetics and Genomics Program, and Epidemiology Program.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Fellowship | Hematology-Oncology | 2011 |
| University of Arkansas College of Medicine | Residency | Pediatrics | 2007 |
| University of Arkansas for Medical Science Program | Internship | Pediatrics | 2005 |
| University of Missouri at Columbus School of Medicine | Medical School | Doctor of Medicine | 2004 |
Organizations
| Organization Name | Role |
|---|---|
| Alpha Omega Alpha | Member |
| American Academy of Pediatrics (AAP) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
| Children's Oncology Group (COG) | Member |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Prevention and Early Detection for Pediatric Hereditary C...
Research Area:
Cancer Survivorship
Genetics and Genomics
Epidemiology (Cancer and Hematology)
Research interests
Development of screening protocols for children with hereditary predisposition to cancer, Identification of children with hereditary predisposition to cancer, Clinical trials for children with brain tumors
